Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125523692 | 12552369 | 2 | F | 20160809 | 20160713 | 20160823 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-120168 | RANBAXY | 86.00 | YR | F | Y | 0.00000 | 20160823 | OT | GB | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125523692 | 12552369 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Unknown | 20 MG, DAILY | Y | 76477 | 20 | MG | |||||||
125523692 | 12552369 | 2 | I | SITAGLIPTIN | SITAGLIPTIN | 1 | Unknown | 100 MG, DAILY | Y | 0 | 100 | MG | |||||||
125523692 | 12552369 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | UNK | Y | 0 | |||||||||
125523692 | 12552369 | 4 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
125523692 | 12552369 | 5 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
125523692 | 12552369 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
125523692 | 12552369 | 7 | C | Gingko biloba | 2 | Unknown | UNK | Y | 0 | ||||||||||
125523692 | 12552369 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | Y | 0 | |||||||||
125523692 | 12552369 | 9 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125523692 | 12552369 | 1 | Product used for unknown indication |
125523692 | 12552369 | 2 | Product used for unknown indication |
125523692 | 12552369 | 3 | Product used for unknown indication |
125523692 | 12552369 | 4 | Product used for unknown indication |
125523692 | 12552369 | 5 | Product used for unknown indication |
125523692 | 12552369 | 6 | Product used for unknown indication |
125523692 | 12552369 | 7 | Product used for unknown indication |
125523692 | 12552369 | 8 | Product used for unknown indication |
125523692 | 12552369 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125523692 | 12552369 | HO |
125523692 | 12552369 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125523692 | 12552369 | Acute kidney injury | |
125523692 | 12552369 | Drug interaction | |
125523692 | 12552369 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |